Plumbagin alleviates obesity‐related asthma: Targeting inflammation, oxidative stress, and the AMPK pathway
Immunity, Inflammation and Disease · 2023-09 · 11 (9)
DOI: 10.1002/iid3.1025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 27.09.2023. Verfasst von Lijie Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Second Ward of Respiratory Department, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, People's Republic of China. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Asthma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Obesity‐related asthma, a specific type of asthma, tends to have more severe symptoms and more frequent exacerbations, and it is insensitive to standard medications. Plumbagin (PLB) has many positive effects on human health. However, it remains unclear whether PLB protects against obesity‐related asthma. The study investigated the effect of PLB on obesity‐related asthma.
Methods
Four‐week‐old male C57BL6/J mice were fed either standard‐chow diet or high‐fat diet (HFD). The mice were sensitized to 100 μg ovalbumin (OVA) once a week and intraperitoneally injected with 1 mg/kg PLB once daily from Week 10 to 11 and then challenged with 10 μg OVA twice a day on Week 12. The lung tissue and bronchoalveolar lavage fluid (BALF) were collected 48 h after the first OVA challenge.
Results
HFD enhanced inflammatory cell infiltration within the airways and increased total inflammatory cell and eosinophil counts, levels of eosinophil‐related inflammatory cytokines, including interleukin‐4 (IL‐4), IL‐5, and eotaxin in BALF, and oxidative stress in the lung tissues of asthmatic mice. PLB reduced inflammatory cell infiltration in the airway walls, levels of eosinophil‐related inflammatory cytokines in BALF, and oxidative stress in lung tissues of obese asthmatic mice. In addition, PLB restored HFD‐induced decreases in adenosine monophosphate‐activated protein kinase (AMPK) phosphorylation.
Conclusion
The study suggested that HFD exacerbated inflammation and oxidative stress, while PLB probably alleviated inflammation and oxidative stress and activated AMPK pathway to attenuate obesity‐associated asthma. Thus, PLB likely had the potential to treat obesity‐related asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Second Ward of Respiratory Department, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, People's Republic of China.
- Ward of Respiratory and Critical Care Department, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, People's Republic of China.
ORCID-Profile: Lihua Liu
Zitieren
APA
Zhang, L., Liang, D., Liu, L., & Liu, L. (2023). Plumbagin alleviates obesity‐related asthma: Targeting inflammation, oxidative stress, and the AMPK pathway. Immunity, Inflammation and Disease, 11(9). https://doi.org/10.1002/iid3.1025
Vancouver
Zhang L, Liang D, Liu L, Liu L. Plumbagin alleviates obesity‐related asthma: Targeting inflammation, oxidative stress, and the AMPK pathway. Immunity, Inflammation and Disease. 2023;11(9). doi:10.1002/iid3.1025
BibTeX
@article{Zhang2023,
author = {Zhang, Lijie and Liang, Dongxue and Liu, Linlin and Liu, Lihua},
title = {Plumbagin alleviates obesity‐related asthma: Targeting inflammation, oxidative stress, and the AMPK pathway},
journal = {Immunity, Inflammation and Disease},
year = {2023},
volume = {11},
number = {9},
doi = {10.1002/iid3.1025}
}
EUVIMED